Thrive Health and Wellness, LLC dba Thrive Health Solutions MARCS-CMS 714891 — July 27, 2026

CLOSEOUT LETTER

• Delivery Method: Via Electronic Mail - Delivery and Read Receipt Requested
• Product: Drugs

---

• Recipient: Doug Hatch; Owner; Thrive Health and Wellness, LLC dba Thrive Health Solutions; 88 Inverness Circle East, Ste A-204; Englewood, CO 80112-5521; United States

• Issuing Office: Center for Drug Evaluation and Research (CDER); United States

---

Dear Mr. Hatch:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter #714891, issued on February 9, 2026. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Matthew J. Lash
Acting Director
Office of Compounding Quality and Compliance
Office of Compliance
Center for Drug Evaluation and Research